CIK 0001070494
- Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 061376651
- Phone
- +1 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- 4 Open-market sale EVP and CCO sold 1,247 shares at $42.56 ($53,072)
- 4 Open-market sale President sold 1,297 shares at $42.56 ($55,200)
- 4 Open-market sale CEO sold 2,960 shares at $42.56 ($125,978)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3/A Insider 3/A
- 4 Open-market sale EVP and CCO sold 27,250 shares at an average $56.25 ($1,532,786)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 12,236 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale President sold 82,295 shares at an average $50.03 ($4,117,244)
- 4 Open-market sale CEO sold 200,000 shares at an average $46.02 ($9,204,692)
- 4 Open-market sale Director sold 26,250 shares at $51.13 ($1,342,178)
- 4 Open-market sale EVP & General Counsel sold 1,072 shares at $49.22 ($52,764)
- 4 Open-market sale EVP and CCO sold 1,501 shares at $49.21 ($73,864)
- 4 Open-market sale CEO sold 6,770 shares at $49.21 ($333,152)
- 4 Open-market sale EVP and CFO sold 11,050 shares at an average $50.59 ($559,034)
Page 12 of 35 · 686 filings